432 JOURNAL OF CHEMICAL RESEARCH 2015
5
-Phenyl-6-(p-tolyl)-2,3-dihydro-pyrazine (2b): White solid;
5,6-Di(4-Methoxyphenyl)-2,3-dihydro-pyrazine (2j): Yellow solid;
o
1
o
1
2
1.4 mg (86% yield); m.p. 115–116 C; H NMR (400 MHz, CDCl ) δ
25.9 mg (88% yield); m.p. 118–120 C; H NMR (400 MHz, CDCl )
3
3
7
4
1
.42–7.38 (m, 2H), 7.34–7.22 (m, 5H), 7.05 (d, J = 8.0 Hz, 2H), 3.68 (s,
δ 7.38–7.35 (m, 4H), 6.79–6.76 (m, 4H), 3.78 (s, 6H), 3.64 (s, 4H);
13
H), 2.30 (s, 3H); C NMR (100 MHz, CDCl ) δ 21.48, 45.84, 45.95,
13
3
C NMR (100 MHz, CDCl ) δ 45.81, 55.39, 113.59, 129.71, 130.63,
3
27.99, 128.00, 128.22, 128.93, 129.68, 135.00, 138.07, 139.92, 160.19,
24
1
59.72, 160.82. Data consistent with literature values.
160.55. HRMS (ESI) calcd for C H N (M+H)+, 249.1392, found
17 17 2
5-(4-Fluorophenyl)-6-(4-methoxyphenyl)-2,3-dihydro-pyrazine
2
49.1389.
-(4-Methoxylphenyl)-6-phenyl-2,3-dihydro-pyrazine (2c): White
o
1
(
2k): White solid; 26.3 mg (93% yield); m.p. 130–131 C; H NMR (400
5
MHz, CDCl ) δ 7.41 (dd, J = 8.5, 5.5 Hz, 2H), 7.33 (d, J = 8.6 Hz, 2H),
o
1
3
solid; 23.8 mg (90% yield); m.p. 93–94 C; H NMR (400 MHz, CDCl )
δ 7.45–7.38 (m, 2H), 7.37–7.30 (m, 3H), 7.26 (t, J = 7.3 Hz, 2H), 6.75 (d,
J = 8.8 Hz, 2H), 3.77 (s, 3H), 3.67 (s, 4H); C NMR (100 MHz, CDCl )
3
6
4
.95 (t, J = 8.6 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 3.79 (s, 3H), 3.66 (s,
13
H); C NMR (100 MHz, CDCl ) δ 45.71, 45.89, 55.39, 104.48, 113.68,
13
3
3
115.34 (d, J = 22.0 Hz), 129.69, 130.12 (d, J = 8.0 Hz), 130.14, 134.30
δ 45.78, 46.00, 55.36, 113.59, 128.02, 128.25, 129.68, 129.70, 130.31,
(
d, J = 3.0 Hz), 159.44, 160.14 (d, J = 163.0 Hz), 162.39. HRMS (ESI)
138.25, 159.56, 160.56, 160.88. HRMS (ESI) calcd for C H N O
17 17 2
+
+
calcd for C H N OF(M+H) , 283.1247, found 283.1250.
(
M+H) , 265.1341, found 265.1338.
-(4-Fluorophenyl)-6-phenyl-2,3-dihydro-pyrazine (2d): White
17 16
2
5
o
1
This work was supported by the Natural Science Foundation of
China.
solid; 24.0 mg (95% yield); m.p. 87–88 C; H NMR (400 MHz, CDCl )
δ 7.43–7.30 (m, 5H), 7.29–7.24 (m, 2H), 6.96–6.91 (m, 2H), 3.69 (s,
3
13
4H); C NMR (100 MHz, CDCl ) δ 45.83, 45.87, 115.35 (d, J = 21.0
3
Hz), 128.00, 128.35, 129.88, 130.12 (d, J = 9.0 Hz), 133.94 (d, J = 4.0
Hz), 137.75, 159.29, 160.16, 163.65 (d, J = 249.0 Hz). HRMS (ESI)
Paper 1503353 doi: 10.3184/174751915X14360237431600
Published online: 9 July 2015
+
calcd for C H N F(M+H) , 253.1141, found 253.1137.
16
14
2
5
-(4-Carboxymethoxylphenyl)-6-phenyl-2,3-dihydro-pyrazine
o
1
(
(
2e): Yellow solid; 28.9 mg (99% yield); m.p. 126–127 C; H NMR
References
400 MHz, CDCl ) δ 7.92 (d, J = 8.3 Hz, 2H), 7.47 (d, J = 8.3 Hz,
3
1
2
3
4
X.X. Guo, D.W. Gu, Z. Wu and W. Zhang, Chem. Rev., 2015, 115, 1622.
X.F. Wu and H. Neumann and M. Beller, Chem. Rev., 2013, 113, 1.
N.T. Patil and Y. Yamamoto, Chem. Rev., 2008, 108, 3395.
S. Ito, S. Takechi, K. Nakahara, N. Kashige and T. Yamaguchi, Chem.
Pharm. Bull., 2010, 58, 825.
2
H), 7.39–7.29 (m, 3H), 7.26–7.23 (m, 2H), 3.89 (s, 3H), 3.73 (s, 4H);
13
C NMR (100 MHz, CDCl ) δ 45.88, 46.10, 52.37, 127.96, 128.07,
3
1
28.41, 129.54, 130.01, 131.05, 137.43, 142.04, 159.93, 160.03, 166.69.
+
HRMS (ESI) calcd for C H N O (M+H) , 293.1290, found 293.1296.
18
17
2
2
5
-(4-Cyanophenyl)-6-phenyl-2,3-dihydro-pyrazine (2f): Yellow
5
6
7
8
9
S. Takechi, T. Yamaguchi, H. Nomura, T. Minematsu, M. Adachi, H.
Kurata and R. Kurata, Biol. Pharm. Bull., 2006, 29, 17.
T. Yamaguchi, H. Nomura, K. Matsunaga, S. Ito, J. Takata and Y. Karube,
Biol. Pharm. Bull., 2003, 26, 1523.
O. Takeda, S. Takechi, S. Ito, H. Omori, T. Katoh and T. Yamaguchi, Biol.
Pharm. Bull. 2007, 30, 1663.
o
1
solid; 22.0 mg (85% yield); m.p. 102–104 C; H NMR (400 MHz,
CDCl ) δ 7.53 (q, J = 8.4 Hz, 4H), 7.37–7.34 (m, 3H), 7.29–7.26 (m,
H), 3.74 (d, J = 1.9 Hz, 4H); C NMR (100 MHz, CDCl ) δ 45.77,
6.10, 113.28, 118.43, 127.87, 128.51, 128.66, 130.19, 132.04, 137.05,
3
13
2
4
1
2
3
41.90, 159.16, 159.53. HRMS (ESI) calcd for C H N (M+H)+,
17
14
3
O. Takeda, S. Takechi, T. Katoh and T. Yamaguchi, Biol. Pharm. Bull.,
60.1188, found 260.1184.
-Naphthyl-6-phenyl-2,3-dihydro-pyrazine (2g): Yellow solid;
2
005, 28, 1161.
5
S. Takechi, K. Nakahara and T. Yamaguchi, Biol. Pharm. Bull., 2010, 33,
379.
o
1
2
8
7
(
1
5.3 mg (89% yield); m.p. 58–59 C; H NMR (400 MHz, CDCl ) δ
.10 (d, J = 8.1 Hz, 1H), 7.78 (t, J = 5.6 Hz, 2H), 7.48–7.41 (m, 2H),
.38–7.32 (m, 4H), 7.13 (t, J = 7.3 Hz, 1H), 7.05 (t, J = 7.5 Hz, 2H), 3.84
s, 4H); C NMR (100 MHz, CDCl ) δ 45.79, 45.91, 124.88, 124.98,
26.16, 126.88, 127.10, 127.58, 127.99, 128.64, 129.63, 129.75, 130.49,
33.77, 135.87, 137.29, 161.27, 161.39. HRMS (ESI) calcd for C H N
3
10 N. Kashige, T. Takeuchi, S. Matsumoto, S. Takechi, F. Miake and T.
Yamaguchi, Biol. Pharm. Bull., 2005, 28, 419.
11 L. Fan, W. Chen and C Qian, Tetrahedron Lett., 2013, 54, 231;
13
3
12
B.J.E. Reich, A.K. Justice, B.T. Beckstead, J.H. Reibenspies and S.A.
Miller, J. Org. Chem., 2004, 69, 1357.
1
(
2
0
17
2
+
13 H. K. Kadam, S. Khan, R.A. Kunkalkar and A.G. Tilve, Tetrahedron Lett.,
013, 54, 1003.
14
M+H) , 285.1392, found 285.1388.
-(4-Methoxyphenyl)-6-naphthyl-2,3-dihydro-pyrazine (2h): Yellow
2
5
A. Hasaninejad, A. Zare, M.A. Zolfigol and M. Shekouhy, Synth. Commun.,
o
1
solid; 29.6 mg (94% yield); m.p. 53–55 C; H NMR (400 MHz, CDCl )
δ 8.09 (d, J = 9.0 Hz, 1H), 7.82–7.79 (m, 2H), 7.48–7.43 (m, 2H), 7.37 (d, J
4.7 Hz, 2H), 7.32 (d, J = 8.7 Hz, 2H), 6.57 (d, J = 8.7 Hz, 2H), 3.85-3.76
m, 4H), 3.65 (s, 3H); C NMR (100 MHz, CDCl ) δ 45.66, 46.01, 55.22,
13.41, 124.96, 125.04, 126.16, 126.87, 127.04, 128.63, 129.24, 129.66,
29.82, 130.54, 133.83, 136.30, 160.41, 160.70, 161.52. HRMS (ESI)
calcd for C H N O(M+H) , 315.1497, found 315.1495.
3
15
=
(
1
1
2
009, 39, 569.
13
16 P. Finkbeiner and B. Nachtsheim, Synthesis, 2013, 45, 979.
17 M. Jereb, D. Vražič, M. Zupan, Tetrahedron, 2011, 67, 1355.
18 Q. Gao, S. Liu, X. Wu and A. Wu, Org. Lett., 2014, 16, 4582.
3
+
21
19
2
2
0
Ed., 2013, 52, 9251.
D. Bandyopadhyay, S. Mukherjee, R.R Rodriguez and B.K. Banik,
Molecules, 2010, 15, 4207.
N. Xu, D.W. Gu, Y.S. Dong, F.P. Yi, L. Cai, X.Y. Wu and X.X. Guo,
Tetrahedron Lett., 2015, 56, 1517.
H.K. Kadam, S. Khan, R.A. Kunkalkar and S.G. Tilve, Tetrahedron Lett.,
2013, 54, 1003.
5
-(4-Methoxyphenyl)-6-(4-methylphenyl)-2,3-dihydro-pyrazine
o
1
(
2i): White solid; 24.2 mg (87% yield); m.p. 108–109 C; H NMR (400
MHz, CDCl ) δ 7.36 (d, J = 8.8 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 7.06
d, J = 8.1 Hz, 2H), 6.76 (d, J = 8.8 Hz, 2H), 3.77 (s, 3H), 3.64 (s, 4H),
.31 (s, 3H); C NMR (100 MHz, CDCl ) δ 21.48, 45.77, 45.88, 55.33,
13.53, 127.97, 128.92, 129.66, 130.48, 135.35, 139.79, 159.67, 160.32,
60.79. HRMS (ESI) calcd for C H N O (M+H)+, 279.1497, found
21
3
(
2
1
1
2
2
2
3
13
3
18 19 2
279.1501.
24 L.Fan, W. Chen and C. Qian, Tetrahedron Lett., 2013, 54, 231.